ACCOUNTS - Final Accounts

Analysis of the maturity of loans is given below:

Registered number: 07150129

MY ULTRA HEALTHCARE LTD

UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

MY ULTRA HEALTHCARE LTD

REGISTERED NUMBER: 07150129

BALANCE SHEET

AS AT 31 DECEMBER 2024

		2024		2023
Note		£		£


Current assets
Debtors: amounts falling due within one year	4	212,944		212,944
Cash at bank and in hand		1		1
		212,945		212,945
Creditors: amounts falling due within one year	5	(361,541)		(348,848)
Net current liabilities			(148,596)		(135,903)
Total assets less current liabilities			(148,596)		(135,903)
Creditors: amounts falling due after more than one year	6		(5,000)		(15,000)

Net liabilities			(153,596)		(150,903)

Capital and reserves
Called up share capital	8	2	2
Profit and loss account		(153,598)	(150,905)
		(153,596)	(150,903)

Page 1

MY ULTRA HEALTHCARE LTD

REGISTERED NUMBER: 07150129

BALANCE SHEET (CONTINUED)

AS AT 31 DECEMBER 2024

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 25 September 2025.

K Hothi

Director

The notes on pages 3 to 7 form part of these financial statements.

Page 2

MY ULTRA HEALTHCARE LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

1.	General information

The Company is a private company, limited by shares, incorporated and domiciled in England within the United Kingdom, registration number 07150129. The Company's registered office is Sterling House RMY, 71 Francis Road, Edgbaston, Birmingham, B16 8SP.
The financial statements are presented in sterling which is the functional currency of the company and the financial statements are rounded to the nearest £1.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

Cash flow
Under Financial Reporting Standard 102, the company is exempt from the requirement to prepare a cash flow statement on the grounds that it qualifies as a small company.

The following principal accounting policies have been applied:

2.2

Going concern

As at 31 December 2024 the company has net liabilities as a result of cumulative losses. The director and shareholders will continue to support the company going forward and the company is expected to make future profits, and as a result the accounts have been prepared on a going concern basis.

2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:

∙the amount of revenue can be measured reliably;

∙it is probable that the Company will receive the consideration due under the contract;

∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and

∙the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

MY ULTRA HEALTHCARE LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

2.5

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

2.6

Debtors

Short term debtors are measured at transaction price, less any impairment.

2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Employees

The average monthly number of employees, including directors, during the year was 1 (2023 - 1).

Page 4

MY ULTRA HEALTHCARE LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

Debtors

					2024	2023
					£	£


Amounts owed by group undertakings	212,930	212,930
Other debtors	14	14
	212,944	212,944

5.	Creditors: Amounts falling due within one year
		2024	2023
		£	£

Bank loans	195,239	185,239
Other taxation and social security	61,178	58,485
Other creditors	104,404	104,404
Accruals and deferred income	720	720
	361,541	348,848

The following liabilities were secured:
	2024	2023
	£	£


Loans	151,572	151,572
	151,572	151,572

Details of security provided:

Loans are secured by way of fixed and floating charges over the assets of the company. The company has not made any repayments since October 2022 and is currently in negotiation with the lender regarding a repayment deal.

Page 5

MY ULTRA HEALTHCARE LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

6.	Creditors: Amounts falling due after more than one year
		2024	2023
		£	£

Bank loans	5,000	15,000
	5,000	15,000

The company took out a Bounce Back Loan in May 2020. The Loan is for a 6 year term, with the first 12 months being interest and repayment free. Interest is then charged on the loan at 2.5% per annum, and capital repayments are due to be repaid in equal instalments over the remaining 5 years. The company made one instalment in June 2020 and a further repayment in June 2022 and since then have been renegotiating repayment terms with the lender and this is still ongoing.

Amounts falling due within one year
Bank loans	195,239	185,239
	195,239	185,239
Amounts falling due 1-2 years
Bank loans	5,000	10,000
	5,000	10,000
Amounts falling due 2-5 years
Bank loans	-	5,000
	-	5,000

	200,239	200,239

Page 6

MY ULTRA HEALTHCARE LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

8.	Share capital
		2024	2023
		£	£

Allotted, called up and fully paid

2 (2023 - 2) Ordinary Shares of £1.00 each	2	2

Related party transactions

During the year the company received loans from directors and shareholders. The balance owed to the directors and shareholders as at 31 December 2024 was £5,475 (2023 - £5,475).
During the year the company received loans from a companies under common control and at 31 December 2024 amounts of £98,915 (2023 - £98,915) were outstanding.
All informal loans are interest free and repayable on demand.

10.	Ultimate parent undertaking

The ultimate parent undertaking is Newco 0114 Limited, a company which is registered in England and Wales. A copy of the parent company accounts can be obtained from The Registrar of Companies, Companies House, Crown Way, Cardiff, CF14 3UZ.

Page 7